ACTG 076--ORAL ZIDOVUDINE IN PREGNANT HIV INFECTED WOMEN AND THEIR CHILDREN

ACTG 076--艾滋病毒感染孕妇及其子女口服齐多夫定

• 批准号: 6274453
• 负责人: Stuart E Starr
• 金额: $ 2.5万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-04-15 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6274453
• 关键词: AIDS therapy; HIV infections; chemoprevention; clinical research; embryo /fetus chemotherapy; female; human pregnant subject; human therapy evaluation; infant human (0-1 year); oral administration; outcomes research; pregnancy disorder chemotherapy; vertical transmission; women's health; zidovudine

To determine whether the vertical HIV transmission rate from mother to infant can be reduced by continuous oral ZDV admin. to HIV infected pregnant women begining at 14 weks gestation with an intrapartum intravenous dose, and oral ZDV admin. to their newborn infants from birth to six weeks of age.

确定 HIV 母婴垂直传播率是否 婴儿可通过连续口服 ZDV 给药来减少。感染艾滋病毒 从妊娠 14 周开始进行产时的孕妇 静脉注射和口服 ZDV 给药。到他们的新生婴儿 出生至六周龄。